476 related articles for article (PubMed ID: 9619781)
1. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.
Grès MC; Julian B; Bourrié M; Meunier V; Roques C; Berger M; Boulenc X; Berger Y; Fabre G
Pharm Res; 1998 May; 15(5):726-33. PubMed ID: 9619781
[TBL] [Abstract][Full Text] [Related]
2. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
Wang FR; Yang XW
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
[TBL] [Abstract][Full Text] [Related]
3. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
[TBL] [Abstract][Full Text] [Related]
4. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
5. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
6. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
Ma L; Yang XW
Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
[TBL] [Abstract][Full Text] [Related]
7. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
[TBL] [Abstract][Full Text] [Related]
8. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.
Yee S
Pharm Res; 1997 Jun; 14(6):763-6. PubMed ID: 9210194
[TBL] [Abstract][Full Text] [Related]
9. Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.
Yamaura Y; Chapron BD; Wang Z; Himmelfarb J; Thummel KE
Drug Metab Dispos; 2016 Mar; 44(3):329-35. PubMed ID: 26700954
[TBL] [Abstract][Full Text] [Related]
10. Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human?
Turco L; Catone T; Caloni F; Di Consiglio E; Testai E; Stammati A
Toxicol In Vitro; 2011 Feb; 25(1):13-20. PubMed ID: 20732406
[TBL] [Abstract][Full Text] [Related]
11. Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics.
Biganzoli E; Cavenaghi LA; Rossi R; Brunati MC; Nolli ML
Farmaco; 1999 Sep; 54(9):594-9. PubMed ID: 10555261
[TBL] [Abstract][Full Text] [Related]
12. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
Cai Y; Xu C; Chen P; Hu J; Hu R; Huang M; Bi H
J Pharmacol Toxicol Methods; 2014; 70(2):175-81. PubMed ID: 25034865
[TBL] [Abstract][Full Text] [Related]
13. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport.
Leonard M; Creed E; Brayden D; Baird AW
Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222
[TBL] [Abstract][Full Text] [Related]
15. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
16. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media.
Ranaldi G; Consalvo R; Sambuy Y; Scarino ML
Toxicol In Vitro; 2003; 17(5-6):761-7. PubMed ID: 14599474
[TBL] [Abstract][Full Text] [Related]
17. An exploratory study of two Caco-2 cell models for oral absorption: a report on their within-laboratory and between-laboratory variability, and their predictive capacity.
Prieto P; Hoffmann S; Tirelli V; Tancredi F; González I; Bermejo M; De Angelis I
Altern Lab Anim; 2010 Oct; 38(5):367-86. PubMed ID: 21105755
[TBL] [Abstract][Full Text] [Related]
18. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
19. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells.
Walgren RA; Walle UK; Walle T
Biochem Pharmacol; 1998 May; 55(10):1721-7. PubMed ID: 9634009
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
Horie K; Tang F; Borchardt RT
Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
